According to the findings of our lab and others, ER-α36 knockdown resulted in reduced proliferation rate together with decreased in vitro migratory and invasive ability of breast cancer cells regardless of conventional ER (ER-α66) status. The gene discussed is ESR1; the disease is breast carcinoma.